Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |